Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: IntegenX Names Schueren as CEO; Applied BioCode Hires Aye as VP

Premium

IntegenX this week announced the appointment of Robert Schueren as CEO.

Schueren most recently served as vice president and general manager of genomics for Agilent Technologies. Prior to joining Agilent in 2010, he was the global head of clinical biomarkers and operations and deputy global head of molecular medicine labs at Genentech. Schueren also served as senior director of development sciences and director of companion diagnostics at Genentech. Schueren has also served as executive vice president and COO of Arcturus Bioscience; and has worked for Accumetrics, Biosite Diagnostics, and Gen-Probe (now Hologic).

Stevan Jovanovich, a founder and past president and CEO of IntegenX, will remain with the company as chief technology officer.


Applied BioCode said this week that it has appointed Michael Aye as vice president of molecular products.

Aye has previously been employed by Focus Diagnostics and Beckman Coulter. Prior to his industrial experience, he spent 10 years in academia focused on research in molecular genetics and microbiology.

Aye obtained a BS in microbiology in 1995 from California State University, Long Beach, and PhD in biology (molecular genetics) in 2001 from the University of California, Irvine.

The Scan

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on additional RNA-seq data from human and mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.

Study Reveals Potential Sex-Specific Role for Noncoding RNA in Depression

A long, noncoding RNA called FEDORA appears to be a sex-specific regulator of major depressive disorder, affecting more women, researchers report in Science Advances.

New mRNA Vaccines Offer Hope for Fighting Malaria

A George Washington University-led team has developed mRNA vaccines for malaria that appear to provide protection in mice, as they report in NPJ Vaccines.